Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo

BACKGROUND AND METHODS: Paclitaxel, a widely used antitumor agent, has limited clinical application due to its hydrophobicity and systemic toxicity. To achieve sustained and targeted delivery of paclitaxel to tumor sites, liposomes composed of egg phosphatidylcholine, cholesterol, and distearolyphos...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cai, Lulu, Wang, Xianhuo, Wang, Wenwen, Qiu, Neng, Wen, Jiaolin, Duan, Xingmei, Li, Xia, Chen, Xiang, Yang, Li, Qian, Zhiyong, Wei, Yuquan, Chen, Lijuan
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2012
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3423151/
https://ncbi.nlm.nih.gov/pubmed/22923988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S32817
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars